{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:24:34Z","timestamp":1783347874737,"version":"3.54.6"},"reference-count":60,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Xerostomia is a common and debilitating condition caused by salivary gland dysfunction, frequently associated with primary Sj\u00f6gren\u2019s syndrome and head and neck radiotherapy. Current management is largely symptomatic and does not address underlying glandular injury. Extracellular vesicles (EVs), including exosomes, have emerged as candidate mediators of intercellular communication that have been proposed for diagnostic and therapeutic applications; however, their translational relevance to xerostomia remains uncertain and is currently supported only by exploratory evidence. This scoping review aimed to map and interpret current evidence on EV-based approaches in xerostomia and salivary gland dysfunction. A scoping review was conducted in accordance with \u201cPreferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR)\u201d checklist. Twenty-five articles were included, comprising 14 primary studies and 11 review articles. Studies were analysed based on application focus, methodological characteristics, reported outcomes, and translational readiness. Most primary studies focused on EVs as diagnostic biomarkers or their roles in immune\u2013epithelial signalling. Therapeutic research was limited and largely confined to human-relevant translational models, namely human peripheral blood mononuclear cell (PBMC) assays and freshly resected human salivary gland tissue-maintained ex vivo. Outcomes were predominantly molecular and cellular, with minimal assessment of salivary flow or patient-reported symptoms. The current evidence base, although biologically plausible, remains exploratory: most included studies are mechanistic, and no clinical efficacy studies in xerostomia were identified. A substantial gap therefore persists between molecular findings and clinically meaningful outcomes, and further translational research is required before any conclusions can be drawn regarding the clinical utility of EV-based approaches.<\/jats:p>","DOI":"10.3390\/ijms27135926","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:50:37Z","timestamp":1782867037000},"page":"5926","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cell and Gene Therapy for Patients Suffering from Xerostomia (Dry Mouth): Positioning Extracellular Vesicles as the Bridge Between Biomarker Discovery and Regenerative Therapy in Xerostomia\u2014A Scoping Review"],"prefix":"10.3390","volume":"27","author":[{"given":"Kumud","family":"Gogna","sequence":"first","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, University Hospital Limerick, Limerick V94 F858, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2552-572X","authenticated-orcid":false,"given":"Hiba Mohammed","family":"Ali","sequence":"additional","affiliation":[{"name":"University of Science and Technology, Omdurman, Sudan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4011-8022","authenticated-orcid":false,"given":"Albert","family":"Leung","sequence":"additional","affiliation":[{"name":"School of Dentistry, Royal College of Surgeons in Ireland, Dublin D18 NY72, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9177-3505","authenticated-orcid":false,"given":"Shahnawaz","family":"Khijmatgar","sequence":"additional","affiliation":[{"name":"School of Dentistry, Royal College of Surgeons in Ireland, Dublin D18 NY72, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1532-5415.2002.50123.x","article-title":"Xerostomia and the geriatric patient","volume":"50","author":"Ship","year":"2002","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1834-7819.2011.01347.x","article-title":"Risk factors and symptoms associated with xerostomia: A cross-sectional study","volume":"56","author":"Villa","year":"2011","journal-title":"Aust. Dent. J."},{"key":"ref_3","unstructured":"Greenberg, M.S., Glick, M., and Ship, J.A. (2015). Burket\u2019s Oral Medicine, PMPH USA. [12th ed.]."},{"key":"ref_4","first-page":"882","article-title":"Salivary gland disorders","volume":"89","author":"Wilson","year":"2014","journal-title":"Am. Fam. Physician"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1834-7819.2010.01229.x","article-title":"Xerostomia: An update for clinicians","volume":"55","author":"Hopcraft","year":"2010","journal-title":"Aust. Dent. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/adj.12284","article-title":"Dry mouth and older people","volume":"60","author":"Thomson","year":"2015","journal-title":"Aust. Dent. J."},{"key":"ref_7","first-page":"1039","article-title":"A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies","volume":"18","author":"Jensen","year":"2010","journal-title":"Support Care Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1002\/cncr.27631","article-title":"Late dysphagia after radiotherapy-based treatment of head and neck cancer","volume":"118","author":"Hutcheson","year":"2012","journal-title":"Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","article-title":"Sj\u00f6gren\u2019s syndrome","volume":"366","author":"Fox","year":"2005","journal-title":"Lancet"},{"key":"ref_10","first-page":"CD003782","article-title":"Parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy","volume":"2015","author":"Davies","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_11","first-page":"CD009603","article-title":"Interventions for the management of dry mouth: Non-pharmacological interventions","volume":"2013","author":"Furness","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"19403","DOI":"10.1073\/pnas.1210662109","article-title":"Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunction","volume":"109","author":"Baum","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","unstructured":"ClinicalTrials.gov (2026, June 12). AQUAx: A Phase 1 Study of AAV2-hAQP1 in Irradiated Parotid Glands, Available online: https:\/\/clinicaltrials.gov\/study\/NCT04043104?term=NCT04043104&rank=1."},{"key":"ref_14","unstructured":"ClinicalTrials.gov (2026, June 12). AQUAx2: A Randomized Double-Blind Placebo-Controlled Phase 2 Study of AAV2-hAQP1, Available online: https:\/\/clinicaltrials.gov\/study\/NCT05926765?term=NCT05926765&rank=1."},{"key":"ref_15","unstructured":"ClinicalTrials.gov (2026, June 12). Long-Term Follow-Up of AAV2-hAQP1-Treated Patients, Available online: https:\/\/clinicaltrials.gov\/study\/NCT05060341?term=NCT05060341&rank=1."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ijrobp.2018.02.034","article-title":"Safety and efficacy of mesenchymal stem cells for radiation-induced xerostomia: A randomized, placebo-controlled phase I\/II trial (MESRIX)","volume":"101","author":"Jensen","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_17","unstructured":"ClinicalTrials.gov (2026, June 12). MESRIX-more: Mesenchymal Stromal Cells for Radiation-Induced Xerostomia, Available online: https:\/\/clinicaltrials.gov\/study\/NCT07290946?term=NCT07290946&rank=1."},{"key":"ref_18","unstructured":"ClinicalTrials.gov (2026, June 12). University of Wisconsin AdMSC Trial for Radiation-Induced Xerostomia, Available online: https:\/\/clinicaltrials.gov\/study\/NCT06392711?term=NCT06392711&rank=1."},{"key":"ref_19","unstructured":"ClinicalTrials.gov (2026, June 12). ASSIX: Adipose-Derived Mesenchymal Stromal Cells for Sj\u00f6gren\u2019s Syndrome Xerostomia, Available online: https:\/\/clinicaltrials.gov\/study\/NCT06805448?term=NCT06805448&rank=1."},{"key":"ref_20","first-page":"1356","article-title":"Salivary gland regeneration: Therapeutic approaches from stem cells to tissue engineering","volume":"34","author":"Lombaert","year":"2016","journal-title":"Stem Cells"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"23743","DOI":"10.3402\/jev.v3.23743","article-title":"Exosomes provide a protective and enriched source of miRNA for biomarker profiling","volume":"3","author":"Cheng","year":"2014","journal-title":"J. Extracell. Vesicles"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Krylova, S.V., and Feng, D. (2023). The machinery of exosomes: Biogenesis, release, and uptake. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021337"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jmb.2015.09.019","article-title":"ExoCarta: A compendium of exosomal cargo","volume":"428","author":"Keerthikumar","year":"2016","journal-title":"J. Mol. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4252\/wjsc.v8.i9.297","article-title":"Stem cell-derived exosomes as a therapeutic tool for cardiovascular disease","volume":"8","author":"Suzuki","year":"2016","journal-title":"World J. Stem Cells"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"D516","DOI":"10.1093\/nar\/gky1029","article-title":"Vesiclepedia 2019: A compendium of extracellular vesicle cargo","volume":"47","author":"Pathan","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41368-023-00274-9","article-title":"Emerging roles of exosomes in oral diseases progression","volume":"16","author":"Wang","year":"2024","journal-title":"Int. J. Oral Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"103260","DOI":"10.1016\/j.autrev.2022.103260","article-title":"Exosomes as biomarkers and therapeutic delivery for autoimmune diseases","volume":"22","author":"Fang","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"8019","DOI":"10.2147\/IJN.S272378","article-title":"Cancer-derived exosomes in cancer biology and biomarker development","volume":"15","author":"Kok","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12951-024-02443-2","article-title":"New frontiers in salivary extracellular vesicles: Transforming diagnostics, monitoring, and therapeutics in oral and systemic diseases","volume":"22","author":"Cui","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e12404","DOI":"10.1002\/jev2.12404","article-title":"MISEV2023: Minimal information for studies of extracellular vesicles","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: Towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int. J. Soc. Res. Methodol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ebiom.2016.06.041","article-title":"Targeting the Ca2+ sensor STIM1 by exosomal transfer of Ebv-miR-BART13-3p is associated with Sj\u00f6gren\u2019s syndrome","volume":"10","author":"Gallo","year":"2016","journal-title":"eBioMedicine"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"110458","DOI":"10.1016\/j.clim.2025.110458","article-title":"Plasma extracellular vesicles promote follicular T helper cell expansion in primary Sj\u00f6gren\u2019s syndrome","volume":"273","author":"Liu","year":"2025","journal-title":"Clin. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1186\/s12967-025-06620-1","article-title":"Saliva-derived extracellular vesicles: A promising therapeutic approach for salivary gland fibrosis","volume":"23","author":"Peng","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s10787-023-01189-x","article-title":"Immunomodulatory effects of umbilical mesenchymal stem cell-derived exosomes on CD4+ T cells in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"31","author":"Ma","year":"2023","journal-title":"Inflammopharmacology"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Upadhyay, A., Tsamchoe, M., Zeitouni, A., Gigliotti, J., Peng, J., Mahmoodi, M., Abo Sharkh, H., Makhoul, N.M., El-Hakim, M., and Wu, J. (2025). Extracellular Vesicles of Salivary Mesenchymal Stem Cells Mitigate Acute Irradiation Injury: Use of an ex-vivo organotypic human slice tissue culture as a disease model. bioRxiv.","DOI":"10.1101\/2025.09.04.674343"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Cross, T., Haug, K.B.F., Brusletto, B.S., Ommundsen, S.K., Tr\u00f8seid, A.-M.S., Aspelin, T., Olstad, O.K., Aass, H.C.D., Galtung, H.K., and Utheim, T.P. (2023). Non-Coding RNA in Salivary Extracellular Vesicles: A New Frontier in Sj\u00f6gren\u2019s Syndrome Diagnostics?. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241713409"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Palanisamy, V., Sharma, S., Deshpande, A., Zhou, H., and Gimzewski, J. (2010). Nanostructural and Transcriptomic Analyses of Human Saliva Derived Exosomes. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0008577"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13075-017-1228-x","article-title":"Identification of potential saliva and tear biomarkers in primary Sj\u00f6gren\u2019s syndrome, utilising the extraction of extracellular vesicles and proteomics analysis","volume":"19","author":"Aqrawi","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13075-019-1961-4","article-title":"Proteomic and histopathological characterisation of sicca subjects and primary Sj\u00f6gren\u2019s syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers","volume":"21","author":"Aqrawi","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Finamore, F., Cecchettini, A., Ceccherini, E., Signore, G., Ferro, F., Rocchiccioli, S., and Baldini, C. (2021). Characterization of Extracellular Vesicle Cargo in Sj\u00f6gren\u2019s Syndrome through a SWATH-MS Proteomics Approach. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094864"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1601-0825.2009.01604.x","article-title":"Exosomes from human saliva as a source of microRNA biomarkers","volume":"16","author":"Michael","year":"2010","journal-title":"Oral Dis."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Chakrabortty, S.K., Xing, S., George, A., Sawicki, B., Lang, S., Nguyen, S., Cole, T.J., Mitsock, E., Ray, C., and Zoukhri, D. (2025). Salivary Extracellular Vesicle RNA Profiling Reveals Biomarkers for Sj\u00f6gren\u2019s. bioRxiv, bioRxiv:2025.2008.2005.668729.","DOI":"10.1101\/2025.08.05.668729"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e133497","DOI":"10.1172\/jci.insight.133497","article-title":"T cell exosome-derived miR-142-3p impairs glandular cell function in Sj\u00f6gren\u2019s syndrome","volume":"5","author":"Jang","year":"2020","journal-title":"JCI Insight"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1093\/rheumatology\/keaa163","article-title":"Circular RNA sequencing indicates circ-IQGAP2 and circ-ZC3H6 as noninvasive biomarkers of primary Sj\u00f6gren\u2019s syndrome","volume":"59","author":"Li","year":"2020","journal-title":"Rheumatology"},{"key":"ref_46","first-page":"240","article-title":"Salivary extracellular vesicles versus whole saliva: New perspectives for the identification of proteomic biomarkers in Sj\u00f6gren\u2019s syndrome","volume":"37","author":"Cecchettini","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jds.2024.10.001","article-title":"A review of the roles of exosomes in salivary gland diseases with an emphasis on primary Sj\u00f6gren\u2019s syndrome","volume":"20","author":"Cui","year":"2025","journal-title":"J. Dent. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00011-025-02053-0","article-title":"Exosomes as immunomodulators in autoimmune inflammation: Implications for primary Sj\u00f6gren\u2019s disease","volume":"74","author":"Hong","year":"2025","journal-title":"Inflamm. Res."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Huang, Y., Li, R., Ye, S., Lin, S., Yin, G., and Xie, Q. (2020). Recent Advances in the Use of Exosomes in Sj\u00f6gren\u2019s Syndrome. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01509"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Jung, J.Y., Kim, J.W., Kim, H.A., and Suh, C.H. (2021). Salivary Biomarkers in Patients with Sj\u00f6gren\u2019s Syndrome-A Systematic Review. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222312903"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"577640","DOI":"10.1016\/j.jneuroim.2021.577640","article-title":"The pathogenic, therapeutic and diagnostic role of exosomal microRNA in the autoimmune diseases","volume":"358","author":"Mirzaei","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e1547","DOI":"10.4317\/jced.62242","article-title":"Mesenchymal stem cell therapies evidence in the treatment of irradiated salivary glands: A scoping review","volume":"16","author":"Moreira","year":"2024","journal-title":"J. Clin. Exp. Dent."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/odi.14692","article-title":"Recent progress in regenerative therapy for damaged salivary glands: From bench to bedside","volume":"30","author":"Takashi","year":"2024","journal-title":"Oral Dis."},{"key":"ref_54","first-page":"102803","article-title":"Exosomal biomarkers in Sj\u00f6gren\u2019s syndrome","volume":"20","author":"Hong","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"ref_55","first-page":"1535750","article-title":"MISEV2018 guidelines","volume":"7","author":"Witwer","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"30087","DOI":"10.3402\/jev.v4.30087","article-title":"Applying extracellular vesicles based therapeutics in clinical trials\u2014an ISEV position paper","volume":"4","author":"Lener","year":"2015","journal-title":"J. Extracell. Vesicles"},{"key":"ref_58","first-page":"1583567","article-title":"Therapeutic applications of extracellular vesicles","volume":"8","author":"Wiklander","year":"2019","journal-title":"J. Extracell. Vesicles"},{"key":"ref_59","first-page":"1420","article-title":"Treatment of Sj\u00f6gren\u2019s syndrome","volume":"64","author":"Fox","year":"2012","journal-title":"Arthritis Care Res."},{"key":"ref_60","first-page":"463","article-title":"Re-engineering extracellular vesicles as smart nanoscale therapeutics","volume":"16","author":"Armstrong","year":"2017","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/13\/5926\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T13:45:59Z","timestamp":1783345559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/13\/5926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":60,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["ijms27135926"],"URL":"https:\/\/doi.org\/10.3390\/ijms27135926","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]}}}